Compare drug alternatives

Vyepti® Alternatives

Vyepti®

(eptinezumab-jjmr)
Vyepti
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat. Vyepti is FDA approved for the following indications: Migraine prevention.

Emgality®

(Galcanezumab)
Emgality
Prescription Only
Emgality is a medication that can be self-administered once a month by injecting it subcutaneously under the skin. It is used for migraine prevention in adults and can also be used to treat cluster headaches during a cluster headache period. The most frequently reported side effect is injection site reactions. Additionally, there are no known drug interactions with Emgality. Emgality is FDA approved for the following indications: Migraine and Cluster Headaches.

Dosage & Administration

Administration
Intravenous infusion (must be diluted)
Subcutaneous
Dosing
100 mg every 3 months or 300 mg (for some patients)
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly.
Latin Shorthand
100 mg q3mo
240 mg LD (120 mg x 2) then 120 mg/mo.

Financial Assistance

Copay
$0
$0
Annual Cap
$200 per infusion for administration costs
$4,900
Assistance Expiration
Calendar year
12 months
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Emgality
Vyepti